Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Is it okay to take anti histamine when on statins?
Drugpatentwatch market analysis industry today?
Drugpatentwatch crizotinib?
Is clarinex off patent?
Excipients list used in dexamethasone creams?

Cost of humira injections?

See the DrugPatentWatch profile for humira

Quick answer

  • Average wholesale price (US): ≈ $5,000 per 40 mg vial (the standard Humira dose).
  • Typical monthly cost if you’re on insurance: $200 – $600 per month (after copays, coinsurance, and deductible).
  • Typical cost if you’re uninsured or under‑insured: $3,000 – $5,000 per month (or $36,000 – $60,000 per year).
  • Savings options:
    • Humira patient‑assistance and discount cards.
    • Biosimilar generics (Amjevita, Cinqair, Amjevita® Biosimilars, etc.) that can cut the price by ~30–40 %.
    • Pharmacy benefit manager (PBM) rebates and 340B pricing (if you qualify).

1. How the price is set

Item What it is Typical amount
List/Wholesale Price The price the manufacturer sets for pharmacies and hospitals. ~$5 000 per 40 mg vial
Average Sales Price (ASP) Average price paid by payers after rebates. ~$4 500–$4 800 per vial
Insurance Coverage Your plan’s formulary, copay/coinsurance, deductible. 5 – 20 % of ASP for many plans
Patient Assistance Manufacturer or charity programs that cover the drug when you’re uninsured or low‑income. 0 % for eligible patients
Biosimilars FDA‑approved generic equivalents of Humira (e.g., Amjevita®, Cinqair®, Amjevita™). ~30–40 % lower than Humira list price

Why the list price is high?
Humira is a biologic (a monoclonal antibody) and is sold under a 12‑year patent. The manufacturer recoups R&D costs and often pays large rebates to commercial insurers, which keeps the list price high but can lower the patient‑pay cost.

2. Typical out‑of‑pocket costs (US)

Scenario Typical cost per month Explanation
Fully insured (private or Medicare Part D) $200 – $600 Copay/coinsurance + deductible. Many plans cover 80–90 % after deductible.
High‑deductible plan, no copay $400 – $800 You pay 20‑30 % of the ASP until the deductible is met, then your plan may cover most.
Uninsured / under‑insured $3,000 – $5,000 2 vials per month at wholesale price (≈ $10,000 / month) minus whatever discount card you can get.
Using a biosimilar (Amjevita, etc.) $2,500 – $3,500 30–40 % cheaper than Humira’s wholesale price.

Tip: Your pharmacy can help calculate exact monthly costs based on your insurance plan and the exact dosing schedule.

3. How to reduce your cost

Method What you need to do Who can help
Humira Patient Assistance Program (PAP) 1. Check eligibility (income < $70,000 for most families in 2023). 2. Fill online form at humira.com/patient-assistance. Humira’s patient assistance team, pharmacist
Humira Discount Card 1. Apply online or at pharmacy. 2. Receive a card that gives a 15‑20 % discount on the pharmacy price. Humira, pharmacy
Biosimilar switch 1. Talk to your doctor about switching to a biosimilar. 2. Get the new prescription. Rheumatologist, primary care
Insurance “step‑in” Some plans require you to start with a biosimilar and then “step‑in” to Humira once the biosimilar is out of the formulary. Pharmacy benefit manager, insurer
340B pricing 340B‑eligible hospitals can buy Humira at ~30‑40 % discount. 340B‑eligible hospitals (rare for individuals)
Rebates & PBM negotiations Your insurance may have negotiated rebates that reduce the effective cost. Your insurer’s PBM

4. Example – 2‑weekly 40 mg dose

Item Price
Vial cost $5,000 (wholesale)
Monthly cost (2 vials) $10,000 (wholesale)
Estimated out‑of‑pocket (insured) $300–$600
Estimated out‑of‑pocket (uninsured) $5,000–$10,000

Note: The actual monthly dose may vary. Some patients receive 80 mg every 4 weeks, which changes the numbers.

5. How to find your exact cost

  1. Ask your pharmacy: They can provide a “pharmacy benefit” cost breakdown.
  2. **Check


Other Questions About Humira :

evaluate the biopharmaceuticals company humira on double down on new winnable customer segments What is the humira copay card? Humira injections cost? Cost humira? Humira crohn's disease? What are common side effects of using humira biosimilars? How long does it take humira to work?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The claim that HUMIRA increases the risk of serious infections that may lead to hospitalization or death is directly supported by the provided FDA label text in Section 5.1.

Category Scores

Warnings
100
Excellent

Accurate Statements

HUMIRA increases risk of serious infections that may lead to hospitalization or death
FDA label (5.1 Serious Infections): “Patients treated with HUMIRA are at increased risk for developing serious infections that may lead to hospitalization or death.”

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The evaluated statement matches the FDA-labeled warning without adding unsupported details.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned